c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8+ memory T-cell survival

European Journal of Immunology

Volumn 45, Issue 9, 2015, Pages 2672-2682

  Giardino Torchia, Maria Letizia ^a   Munitic, Ivana ^a,c   Castro, Ehydel ^a   Herz, Jasmin ^b   Mcgavern, Dorian B ^b   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c University of Rijeka   (Croatia)

Author keywords

4 1BB; CD8+ memory T cell; Lymphocytic choriomeningitis virus; Signal transduction; T cell memory; Ubiquitination

Indexed keywords

CD137 ANTIGEN; CD8 ANTIGEN; CELLULAR INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; BIRC2 PROTEIN, MOUSE; BIRC3 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; ENZYME ACTIVITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CULTURE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; MUTATION; PATHOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION; UBIQUITINATION; VIROLOGY;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD137; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGIC MEMORY; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; MUTATION; NF-KAPPA B; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84940962244     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445342     Document Type: Article

References (43)

1. Srinivasula, S. M. and Ashwell, J. D., IAPs: what′s in a name? Mol. Cell. 2008. 30: 123-135.
2. Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V. et al., Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. USA 2008. 105: 11778-11783.
3. Bertrand, M. J., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J., Gillard, J. W. et al., cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell. 2008. 30: 689-700.
4. Varfolomeev, E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J. et al., c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J. Biol. Chem. 2008. 283: 24295-24299.
5. Wertz, I. E. and Dixit, V. M., Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2010. 2: a003350.
6. Moulin, M., Anderton, H., Voss, A. K., Thomas, T., Wong, W. W., Bankovacki, A., Feltham, R. et al., IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 2012. 31: 1679-1691.
7. Vallabhapurapu, S. and Karin, M., Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009. 27: 693-733.
8. Sun, S. C., Non-canonical NF-κB signaling pathway. Cell Res. 2011. 21: 71-85.
9. Ben-Neriah, Y., Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 2002. 3: 20-26.
10. Fulda, S. and Vucic, D., Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 2012. 11: 109-124.
11. Lee, S., Challa-Malladi, M., Bratton, S. B. and Wright, C. W., Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). J. Biol. Chem. 2014. 289: 30680-30689.
12. Kaech, S. M. and Cui, W., Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 2012. 12: 749-761.
13. Ahlers, J. D. and Belyakov, I. M., Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010. 115: 1678-1689.
14. Croft, M., The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 2009. 9: 271-285.
15. Allam, A., Conze, D. B., Giardino Torchia, M. L., Munitic, I., Yagita, H., Sowell, R. T., Marzo, A. L. et al., The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood 2009. 114: 2121-2130.
16. Wortzman, M. E., Clouthier, D. L., McPherson, A. J., Lin, G. H. and Watts, T. H., The contextual role of TNFR family members in CD8(+) T-cell control of viral infections. Immunol. Rev. 2013. 255: 125-148.
17. Croft, M., Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 2003. 3: 609-620.
18. Takahashi, C., Mittler, R. S. and Vella, A. T., Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 1999. 162: 5037-5040.
19. Starck, L., Scholz, C., Dorken, B. and Daniel, P. T., Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP(short) via phosphatidylinositol 3-kinase and AKT/protein kinase B. Eur. J. Immunol. 2005. 35: 1257-1266.
20. Lee, H. W., Park, S. J., Choi, B. K., Kim, H. H., Nam, K. O. and Kwon, B. S., 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. J. Immunol. 2002. 169: 4882-4888.
21. Wang, C., Lin, G. H., McPherson, A. J. and Watts, T. H., Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 2009. 229: 192-215.
22. Sabbagh, L., Srokowski, C. C., Pulle, G., Snell, L. M., Sedgmen, B. J., Liu, Y., Tsitsikov, E. N. et al., A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc. Natl. Acad. Sci. USA 2006. 103: 18703-18708.
23. Watts, T. H., TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 2005. 23: 23-68.
24. McPherson, A. J., Snell, L. M., Mak, T. W. and Watts, T. H., Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J. Biol. Chem. 2012. 287: 23010-23019.
25. Gentle, I. E., Moelter, I., Lechler, N., Bambach, S., Vucikuja, S., Hacker, G. and Aichele, P., Inhibitors of apoptosis proteins (IAPs) are required for effective T-cell expansion/survival during antiviral immunity in mice. Blood 2014. 123: 659-668.
26. Conze, D. B., Zhao, Y. and Ashwell, J. D., Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2. PLoS Biol. 2010. 8: e1000518.
27. Giardino Torchia, M. L., Conze, D. B., Jankovic, D. and Ashwell, J. D., Balance between NF-κB p100 and p52 regulates T cell costimulation dependence. J. Immunol. 2013. 190: 549-555.
28. Lin, G. H., Snell, L. M., Wortzman, M. E., Clouthier, D. L. and Watts, T. H., GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology. J. Immunol. 2013. 190: 4627-4639.
29. Bertram, E. M., Lau, P. and Watts, T. H., Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 2002. 168: 3777-3785.
30. McDermott, D. S. and Varga, S. M., Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J. Immunol. 2011. 187: 5568-5576.
31. Hikono, H., Kohlmeier, J. E., Takamura, S., Wittmer, S. T., Roberts, A. D. and Woodland, D. L., Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 2007. 204: 1625-1636.
32. Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J. et al., Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009. 31: 296-308.
33. Joshi, N. S., Cui, W., Dominguez, C. X., Chen, J. H., Hand, T. W. and Kaech, S. M., Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells. J. Immunol. 2011. 187: 4068-4076.
34. Zhu, Y., Zhu, G., Luo, L., Flies, A. S. and Chen, L., CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 2007. 109: 4882-4889.
35. Pulle, G., Vidric, M. and Watts, T. H., IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J. Immunol. 2006. 176: 2739-2748.
36. Beug, S. T., Cheung, H. H., LaCasse, E. C. and Korneluk, R. G., Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol. 2012. 33: 535-545.
37. Gardam, S., Turner, V. M., Anderton, H., Limaye, S., Basten, A., Koentgen, F., Vaux, D. L. et al., Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 2011. 117: 4041-4051.
38. Dougan, M., Dougan, S., Slisz, J., Firestone, B., Vanneman, M., Draganov, D., Goyal, G. et al., IAP inhibitors enhance co-stimulation to promote tumor immunity. J. Exp. Med. 2010. 207: 2195-2206.
39. Rowe, A. M., Murray, S. E., Raue, H. P., Koguchi, Y., Slifka, M. K. and Parker, D. C., A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory. J. Immunol. 2013. 191: 3663-3672.
40. Prlic, M., Blazar, B. R., Khoruts, A., Zell, T. and Jameson, S. C., Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 2001. 167: 5664-5668.
41. Cannons, J. L., Bertram, E. M. and Watts, T. H., Cutting edge: profound defect in T cell responses in TNF receptor-associated factor 2 dominant negative mice. J. Immunol. 2002. 169: 2828-2831.
42. Dutko, F. J. and Oldstone, M. B., Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 1983. 64: 1689-1698.
43. McCausland, M. M. and Crotty, S., Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J. Virol. Methods 2008. 147: 167-176.